Recanalization therapies in acute ischemic stroke: Pharmacological agents, devices, and combinations

Stroke Research and Treatment

Volumn , Issue , 2010, Pages

  Sharma, Vijay K ^a   Teoh, Hock Luen ^a   Wong, Lily Y H ^a   Su, Jie ^a   Ong, Benjamin K C ^a   Chan, Bernard P L ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANCROD; DALTEPARIN; DESMOTEPLASE; FIBRINOLYTIC AGENT; NADROPARIN; PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CLINICAL TRIAL; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; PRIORITY JOURNAL; RECANALIZATION; REVASCULARIZATION; REVIEW; STROKE;

EID: 77955975020     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.4061/2010/672064     Document Type: Review

References (57)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group The New England Journal of Medicine 1995 333 1581 1587
2. Thomassen L., Waje-Andreassen U., Naess H., Aarseth J., Russell D., Doppler ultrasound and clinical findings in patients with acute ischemic stroke treated with intravenous thrombolysis European Journal of Neurology 2005 12 6 462 465
3. Rha J. H., Saver J. L., The impact of re-canalization on ischemic stroke outcome: a meta-analysis Stroke 2007 38 967 973
4. Hacke W., Kaste M., Fieschi C., Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the european cooperative aAcute stroke study (ECASS) Journal of the American Medical Association 1995 274 13 1017 1025
5. Hacke W., Kaste M., Fieschi C., Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) The Lancet 1998 352 9136 1245 1251
6. Clark W. M., Albers G. W., Madden K. P., Hamilton S., The rtPA (Alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study Stroke 2000 31 4 811 816
7. Clark W. M., Wissman S., Albers G. W., Jhamandas J. H., Madden K. P., Hamilton S., Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset the ATLANTIS studya randomized controlled trial Journal of the American Medical Association 1999 282 21 2019 2026
8. The ATLANTIS, ECASS and NINDS rt-PA study group investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS and NINDS rt-PA stroke trials The Lancet 2004 363 768 774
9. Albers G. W., Thijs V. N., Wechsler L., Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study Annals of Neurology 2006 60 5 508 517
10. Davis S. M., Donnan G. A., Parsons M. W., Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial The Lancet Neurology 2008 7 4 299 309
11. Hacke W., Kaste M., Bluhmki E., Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke The New England Journal of Medicine 2008 359 13 1317 1329
12. http://www.stroketrial.org/
13. Zangerle A., Kiechl S., Spiegel M., Recanalization after thrombolysis in stroke patients: predictors and prognostic implications Neurology 2007 68 1 39 44
14. Ribo M., Alvarez-Sabin J., Montaner J., Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques Stroke 2006 37 4 1000 1004
15. Thomassen L., Bakke S. J., Endovascular reperfusion therapy in acute ischaemic stroke Acta Neurologica Scandinavica 2007 115 22 29
16. Hacke W., Albers G., Al-Rawi Y., The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase Stroke 2005 36 1 66 73
17. Furlan A. J., Eyding D., Albers G. W., Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset Stroke 2006 37 5 1227 1231
18. Hacke W., Furlan A. J., Al-Rawi Y., Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study The Lancet Neurology 2009 8 2 141 150
19. Sherman D. G., Atkinson R. P., Chippendale T., Intravenous ancrod for treatment of acute ischemic stroke. The STAT study: a randomized controlled trial Journal of the American Medical Association 2000 283 18 2395 2403
20. Levy D. E., Trammel J., Wasiewski W. W., Ancrod for acute ischemic stroke: a new dosing regimen derived from analysis of prior ancrod stroke studies Journal of Stroke and Cerebrovascular Diseases 2009 18 1 23 27
21. Kay R., Wong K. S., Yu Y. L., Low-molecular-weight heparin for the treatment of acute ischemic stroke The New England Journal of Medicine 1995 333 24 1588 1593
22. Berge E., Abdelnoor M., Nakstad P. H., Sandset P. M., Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in acute embolic stroke trial The Lancet 2000 355 9211 1205 1210
23. Zhang L., Zhang Z. G., Zhang R., Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke Circulation 2003 107 22 2837 2843
24. Mandava P., Lick S. D., Rahman M. A., Initial safety experience of abciximab and heparin for acute ischemic stroke Cerebrovascular Diseases 2005 19 4 276 278
25. The Abciximab in Ischemic Stroke Investigators, Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study Stroke 2000 31 3 601 609
26. Adams H. P. Jr., Hacke W., Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial Stroke 2005 36 4 880 890
27. Adams H. P. Jr., Effron M. B., Torner J., Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: abciximab in emergency treatment of stroke trial (AbESTT-II) Stroke 2008 39 1 87 99
28. del Zoppo G. J., Higashida R. T., Furlan A. J., Pessin M. S., Rowley H. A., Gent M., PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in acute cerebral thromboembolism Stroke 1998 29 1 4 11
29. Furlan A., Higashida R., Wechsler L., Schultz G., Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial Journal of the American Medical Association 1999 282 21 2003 2011
30. Hill M. D., Rowley H. A., Adler F., Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS Stroke 2003 34 8 1925 1931
31. Lewandowski C. A., Frankel M., Tomsick T. A., Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: emergency management of stroke (EMS) bridging trial Stroke 1999 30 12 2598 2605
32. Broderick J., Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the interventional management of stroke study Stroke 2004 35 4 904 911
33. Smith W. S., Sung G., Starkman S., Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial Stroke 2005 36 7 1432 1438
34. Adams H. P. Jr., del Zoppo G., Alberts M. J., Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Circulation 2007 115 e478 e534
35. Becker K. J., Brott T. G., Approval of the MERCI clot retriever: a critical view Stroke 2005 36 2 400 403
36. Qureshi A. I., Siddiqui A. M., Suri M. F. K., Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study Neurosurgery 2002 51 5 1319 1329
37. Noser E. A., Shaltoni H. M., Hall C. E., Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke 2005 36 292 296
38. Sugg R. M., Malkoff M. D., Noser E. A., Endovascular recanalization of internal carotid artery occlusion in acute ischemic stroke American Journal of Neuroradiology 2005 26 10 2591 2594
39. Abou-Chebl A., Bajzer C. T., Krieger D. W., Furlan A. J., Yadav J. S., Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis Stroke 2005 36 10 2286 2288
40. Gupta R., Vora N. A., Horowitz M. B., Multimodal reperfusion therapy for acute ischemic stroke: factors predicting vessel recanalization Stroke 2006 37 4 986 990
41. Smith W. S., Sung G., Saver J., Mechanical thrombectomy for acute ischemic stroke: final results of the multi MERCI trial Stroke 2008 39 4 1205 1212
42. Spengos K., Behrens S., Daffertshofer M., Dempfle C. E., Hennerici M., Acceleration of thrombolysis with ultrasound through the cranium in a flow model Ultrasound in Medicine and Biology 2000 26 5 889 895
43. Braaten J. V., Goss R. A., Francis C. W., Ultrasound reversibly disaggregates fibrin fibers Thrombosis and Haemostasis 1997 78 3 1063 1068
44. Kondo I., Mizushige K., Ueda T., Histological observations and the process of ultrasound contrast agent enhancement of tissue plasminogen activator thrombolysis with ultrasound exposure Japanese Circulation Journal 1999 63 6 478 484
45. Suchkova V., Siddiqi F. N., Carstensen E. L., Dalecki D., Child S., Francis C. W., Enhancement of fibrinolysis with 40-kHz ultrasound Circulation 1998 98 10 1030 1035
46. Daffertshofer M., Gass A., Ringleb P., Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial Stroke 2005 36 7 1441 1446
47. Eggers J., Knig I. R., Koch B., Hndler G., Seidel G., Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study Stroke 2008 39 5 1470 1475
48. Alexandrov A. V., Molina C. A., Grotta J. C., Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke The New England Journal of Medicine 2004 351 21 2170 2178
49. Sharma V. K., Rathakrishnan R., Ong B. K. C., Chan B. P. L., Ultrasound assisted thrombolysis in acute ischaemic stroke: preliminary experience in Singapore Annals of the Academy of Medicine Singapore 2008 37 9 778 782
50. Saqqur M., Tsivgoulis G., Molina C. A., Design of a PROspective multi-national CLOTBUST collaboration on reperfusion therapies for stroke (CLOTBUST-PRO) International Journal of Stroke 2008 3 1 66 72
51. IMS II Trial Investigators, The interventional management of stroke (IMS) II study Stroke 2007 38 2127 2135
52. Shi W. T., Forsberg F., Vaidyanathan P., Tornes A., stensen J., Goldberg B. B., The influence of acoustic transmit parameters on the destruction of contrast microbubbles in vitro Physics in Medicine and Biology 2006 51 16 4031 4045
53. Everbach E. C., Francis C. W., Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1MHz Ultrasound in Medicine and Biology 2000 26 7 1153 1160
54. Molina C. A., Ribo M., Rubiera M., Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator Stroke 2006 37 2 425 429
55. Alexandrov A. V., Mikulik R., Ribo M., A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke Stroke 2008 39 5 1464 1469
56. Barreto A. D., Sharma V. K., Lao A. Y., Safety and dose-escalation study design of transcranial ultrasound in clinical SONolysis for acute ischemic stroke: the TUCSON trial International Journal of Stroke 2009 4 1 42 48
57. Zivin J. A., Albers G. W., Bornstein N., Effectiveness and safety of transcranial laser therapy for acute ischemic stroke Stroke 2009 40 4 1359 1364